Skip to content

Outcome Predictors of Trachea-esophageal Fistula

Outcome Predictors of Trachea-esophageal Fistula in Neonates Admitted to AUCH

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05847101
Enrollment
100
Registered
2023-05-06
Start date
2023-06-30
Completion date
2024-05-31
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheo Esophageal Fistula

Brief summary

In the present study, the investigator aim to evaluate the prevalence, factors affecting outcome and the outcome of neonates with tracheoesophageal fistula.

Detailed description

Tracheoesophageal fistula is a connection between the esophagus and the trachea. Tracheoesophageal fistula (TEF) represents one of the most common congenital anomalies seen in infants, Infants with TEF classically present with respiratory distress, feeding difficulties, choking, and risk for aspiration. TEF is most commonly associated with other congenital anomalies, particularly cardiac defects. Esophageal atresia (EA) is a related congenital malformation with a similar presentation to TEF and can occur with or without the presence of a fistula. Although the events leading to separation of the primitive trachea and esophagus are not completely understood, the most commonly accepted hypothesis is that a defect in the lateral septation of the foregut into the trachea and esophagus causes TEF and EA. The trachea and esophagus develop from a common primitive foregut, and at approximately 4 weeks of gestation, the developing respiratory and gastrointestinal tracts are separated by epithelial ridges. The foregut divides into a ventral respiratory tract and a dorsal esophageal tract; the fistula tract is thought to derive from an embryonic lung bud that fails to undergo branching. These defects of mesenchymal proliferation are thought to lead to TEF formation. The incidence of TEF is approximately 1 in 3500 births. EA and TEF are classified according to their anatomic configuration.

Interventions

PROCEDURETracheoesophageal fistula repair

Tracheoesophageal fistula repair

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days

Inclusion criteria

* Patients diagnosed with tracheoesophageal fistula are/below the age of 28 days.

Exclusion criteria

* Patients above the age of 28 days. * Patients diagnosed with other diseases. * Patients with acquired tracheoesophageal fistula.

Design outcomes

Primary

MeasureTime frameDescription
Affection of tracheo-esophageal fistula in neanatesBaselineevaluate factors affecting outcome of neonates with tracheoesophageal fistula.

Contacts

Primary ContactAssem Abd Elrazek, doctor
assemabdelrazek857@gmail.com+201222886620

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026